WHO ICTRP trial
Effectiveness of extended dose of tranexamic acid for 48 hours vs single dose…
TCTR20190114001 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20190114001 |
|---|---|
| Public title | Effectiveness of extended dose of tranexamic acid for 48 hours vs single dose perioperative tranexamic acid on reduction of blood loss after primary total knee arthroplasty: A randomized controlled trial |
| Scientific title | Effectiveness of extended dose of tranexamic acid for 48 hours vs single dose perioperative tranexamic acid on reduction of blood loss after primary total knee arthroplasty: A randomized controlled trial |
| Primary sponsor | Faculty of Medicine, Prince of Songkla university |
| Secondary sponsors | Faculty of Medicine, Prince of Songkla university |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Thailand |
| Conditions | Total knee replacement Total knee replacement Oral tranexamic acid;Total knee replacement Oral tranexamic acid |
| Interventions | 3 capsules of 250mg oral tranexamic acid at 8 hours post-operative and at the interval of 8 hours until 48 hours post-operative. ,3 capsules of placebo identical to oral tranexamic acid at 8 hours post-operative and at the interval of 8… |
| Registration date | Jan 14, 2019 |
| Target size | 94 |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: